Chlamydial induction of hydrosalpinx in 11 strains of mice reveals multiple host mechanisms for preventing upper genital tract pathology

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Chen, Jianlin ^a,b   Zhang, Hongbo ^a,b   Zhou, Zhou ^a   Yang, Zhangsheng ^a   Ding, Yiling ^a   Zhou, Zhiguang ^b   Zhong, Edward ^b   Arulanandam, Bernard ^c   Baseman, Joel ^d   Zhong, Guangming ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

^d UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHLAMYDIASIS; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; FEMALE GENITAL TRACT INFECTION; HOST RESISTANCE; HYDROSALPINX; INTRAUTERINE INFECTION; MOUSE; MOUSE STRAIN; NONHUMAN; STRAIN DIFFERENCE; CHLAMYDIA MURIDARUM; ESTRUS CYCLE; GENITAL SYSTEM; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; IN VITRO STUDY; IN VIVO STUDY; LOWER GENITAL TRACT; NEUTROPHIL CHEMOTAXIS; OVIDUCT; TISSUE HOMOGENATE; UPPER GENITAL TRACT; ANIMAL; CHLAMYDIA; DISEASE MODEL; GENETICS; GENITAL TRACT INFECTION; HAPLOTYPE; HOST PATHOGEN INTERACTION; METABOLISM; MICROBIOLOGY; PATHOLOGY;

CYTOKINE; H2 ANTIGEN;

ANIMALS; CHLAMYDIA INFECTIONS; CHLAMYDIA MURIDARUM; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; H-2 ANTIGENS; HAPLOTYPES; HOST-PATHOGEN INTERACTIONS; MICE; REPRODUCTIVE TRACT INFECTIONS;

EID: 84899699709     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0095076.g002     Document Type: Article

References (22)

1. Sherman KJ, Daling JR, Stergachis A, Weiss NS, Foy HM, et al. (1990) Sexually transmitted diseases and tubal pregnancy. Sex Transm Dis 17: 115-121.
2. Stephens RS (2003) The cellular paradigm of chlamydial pathogenesis. Trends Microbiol 11: 44-51. (Pubitemid 36084355)
3. Cheng W, Shivshankar P, Li Z, Chen L, Yeh IT, et al. (2008) Caspase-1 contributes to Chlamydia trachomatis-induced upper urogenital tract inflammatory pathologies without affecting the course of infection. Infect Immun 76: 515-522. (Pubitemid 351251721)
4. Cotter TW, Meng Q, Shen ZL, Zhang YX, Su H, et al. (1995) Protective efficacy of major outer membrane protein-specific immunoglobulin A (IgA) and IgG monoclonal antibodies in a murine model of Chlamydia trachomatis genital tract infection. Infect Immun 63: 4704-4714.
5. Shah AA, Schripsema JH, Imtiaz MT, Sigar IM, Kasimos J, et al. (2005) Histopathologic changes related to fibrotic oviduct occlusion after genital tract infection of mice with Chlamydia muridarum. Sex Transm Dis 32: 49-56. (Pubitemid 40054161)
6. de la Maza LM, Pal S, Khamesipour A, Peterson EM (1994) Intravaginal inoculation of mice with the Chlamydia trachomatis mouse pneumonitis biovar results in infertility. Infect Immun 62: 2094-2097. (Pubitemid 24137019)
7. Swenson CE, Schachter J (1984) Infertility as a consequence of chlamydial infection of the upper genital tract in female mice. Sex Transm Dis 11: 64-67. (Pubitemid 14115769)
8. Morrison RP, Caldwell HD (2002) Immunity to murine chlamydial genital infection. Infect Immun 70: 2741-2751. (Pubitemid 34564127)
9. Ramsey KH, Sigar IM, Rana SV, Gupta J, Holland SM, et al. (2001) Role for inducible nitric oxide synthase in protection from chronic Chlamydia trachomatis urogenital disease in mice and its regulation by oxygen free radicals. Infect Immun 69: 7374-7379. (Pubitemid 33086561)
10. Darville T, O'Neill JM, Andrews CW Jr, Nagarajan UM, Stahl L, et al. (2003) Toll-like receptor-2, but not Toll-like receptor-4, is essential for development of oviduct pathology in chlamydial genital tract infection. J Immunol 171: 6187-6197. (Pubitemid 37467242)
11. Budrys NM, Gong S, Rodgers AK, Wang J, Louden C, et al. (2012) Chlamydia trachomatis antigens recognized in women with tubal factor infertility, normal fertility, and acute infection. Obstet Gynecol 119: 1009-1016.
12. Rodgers AK, Budrys NM, Gong S, Wang J, Holden A, et al. (2011) Genomewide identification of Chlamydia trachomatis antigens associated with tubal factor infertility. Fertil Steril 96: 715-721.
13. Tang L, Zhang H, Lei L, Gong S, Zhou Z, et al. (2013) Oviduct infection and hydrosalpinx in DBA1/j mice is induced by intracervical but not intravaginal inoculation with Chlamydia muridarum. PLoS One 8: e71649.
14. Chen L, Lei L, Chang X, Li Z, Lu C, et al. (2010) Mice deficient in MyD88 Develop a Th2-dominant response and severe pathology in the upper genital tract following Chlamydia muridarum infection. J Immunol 184: 2602-2610.
15. Chen C, Chen D, Sharma J, Cheng W, Zhong Y, et al. (2006) The hypothetical protein CT813 is localized in the Chlamydia trachomatis inclusion membrane and is immunogenic in women urogenitally infected with C. trachomatis. Infect Immun 74: 4826-4840. (Pubitemid 44157270)
16. Zhong G, Fan P, Ji H, Dong F, Huang Y (2001) Identification of a chlamydial protease-like activity factor responsible for the degradation of host transcription factors. J Exp Med 193: 935-942. (Pubitemid 32525866)
17. Zhong G, Reis e Sousa C, Germain RN (1997) Production, specificity, and functionality of monoclonal antibodies to specific peptide-major histocompatibility complex class II complexes formed by processing of exogenous protein. Proc Natl Acad Sci U S A 94: 13856-13861. (Pubitemid 28009674)
18. Mashruwala MA, Smith AK, Lindsey DR, Moczygemba M, Wetsel RA, et al. (2011) A defect in the synthesis of Interferon-gamma by the T cells of Complement-C5 deficient mice leads to enhanced susceptibility for tuberculosis. Tuberculosis (Edinb) 91 Suppl 1: S82-89.
19. Tuite A, Elias M, Picard S, Mullick A, Gros P (2005) Genetic control of susceptibility to Candida albicans in susceptible A/J and resistant C57BL/6J mice. Genes Immun 6: 672-682. (Pubitemid 41741712)
20. Durigutto P, Macor P, Ziller F, De Maso L, Fischetti F, et al. (2013) Prevention of arthritis by locally synthesized recombinant antibody neutralizing complement component C5. PLoS One 8: e58696.
21. Copland DA, Hussain K, Baalasubramanian S, Hughes TR, Morgan BP, et al. (2010) Systemic and local anti-C5 therapy reduces the disease severity in experimental autoimmune uveoretinitis. Clin Exp Immunol 159: 303-314.
22. Howell GR, Soto I, Ryan M, Graham LC, Smith RS, et al.(2013). Deficiency of complement component 5 ameliorates glaucoma in DBA/2J mice. J Neuroinflammation 10: 76.